The Emperor Total Artificial Heart is a new motor-driven evolution of the clinically proven SynCardia Total Artificial Heart (STAH).
It maintains the key design properties of the STAH but eliminates the need for external pneumatic drivers, improving autonomy.
In vitro and in vivo testing demonstrate the Emperor TAH's ability to maintain stable support, hemodynamic performance, and physiological equivalence to the STAH.
Advanced Technology
The Emperor TAH utilizes an electromechanical actuation platform that enhances autoregulation and afterload independence.
Hemodynamic Equivalence
Testing shows the Emperor TAH maintains constant cardiac output across varying pressures, similar to the pneumatic STAH.
Surgical Feasibility
Initial in vivo implantation in porcine models confirms the Emperor TAH's anatomical compatibility and stable support during acute conditions.
- The Emperor TAH demonstrates effective autoregulation to changing hemodynamic conditions, comparable to the STAH.
- In vivo testing confirms the physiological performance and reliability of the shared architecture, paving the way for future clinical translation.
The introduction of the Emperor Total Artificial Heart represents a significant advancement in artificial heart technology, maintaining the proven performance of the SynCardia STAH in a motor-driven design. The successful in vivo testing sets the stage for further development and clinical studies.